- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 13, 2026 | 2.33M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 739K sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 189K sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$1.19M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$1.6M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $10.27M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $6.67M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$1.27M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $652K |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $2.86M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $5.83M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $4.04M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $5.85M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $4.07M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $10.42M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $695K |
| Total Assets | Q1 2026 · Mar 31, 2026 | $12.52M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $2.8M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$4.00 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$12.55 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $1.92M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $995K |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $773K |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $1.38M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$2.96M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$2.37M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$2.69M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$2.38M |